Product review · Published October 7, 2026 · Updated October 7, 2026
Hims Sildenafil Chews review
Hims Sildenafil Chews: a compounded dosage form without tadalafil, with formulation, cost, evidence and availability examined to prepare for assessment of one identifiable prescription.
Editorial document research · How we use sources
A consultation about Hims Sildenafil Chews should begin with what it actually contains and why it is being considered. The documented offer is a berry-flavored sildenafil-only chew. This review uses that specific preparation to organize questions about assessment, prescribing responsibility and follow-up, rather than treating a company's entire catalog as one treatment.
In this article
Keep this question in view
The important distinction is a compounded dosage form without tadalafil. The unresolved question is selected strength, count and administration instructions.
The exact product
The clinical decision includes a compounded dosage form without tadalafil. Describe the symptom and prior treatment history before asking for the advertised product by name. The clinician may recommend another preparation or further assessment. A selected online package is not a completed prescription decision, and a familiar ingredient does not settle whether the proposed combination or format is appropriate. The record below identifies the offer without supplying use instructions.
| Detail | Record |
|---|---|
| Provider | Hims |
| Listed active ingredients | Sildenafil |
| Dosage form | Compounded berry-flavored chew |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Hims: current ED treatment catalog |
Price, supply and payment
It is reasonable to discuss affordability during assessment. The public figure for this product is From $30/month. Confirm what the first charge covers, what changes if a different prescription is recommended, and whether an assessment fee is separate. A quote for one supply should not be assumed to apply after a clinical adjustment. Ask for the accepted quantity, term and renewal amount once the actual treatment is known.
| Detail | Record |
|---|---|
| Public headline | From $30/month |
| Single ED ingredient | Sildenafil |
| Different Hims offering | 3-in-1 Hard Mints also contain tadalafil and B12 |
| Regulatory category | Compounded chew, not an approved generic tablet |
What the research can support
A useful prescribing explanation connects the patient's concern to relevant evidence. Here that evidence concerns sildenafil tablet research; a matched trial of the finished chew was not verified; it leaves selected strength, count and administration instructions unsettled. Ask why the proposed preparation is being considered and what simpler or differently formulated options were evaluated. A marketing claim does not supply an individualized rationale, and clinician involvement does not transform evidence for one preparation into evidence for every related product.
| Detail | Record |
|---|---|
| Evidence boundary | sildenafil tablet research; a matched trial of the finished chew was not verified |
| Not established here | selected strength, count and administration instructions |
| Clinical and regulatory references | MedlinePlus: Sildenafil · FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · MedlinePlus: Tadalafil |
Safety questions for the prescriber
Bring a complete account of prescriptions, nonprescription products and intermittent medicine use. Specifically disclose nitrates or nitrites, riociguat, blood-pressure treatment and other ED medication. Relevant heart, kidney, liver and eye history may change the assessment. Do not stop an unrelated prescription or overlap Hims Sildenafil Chews with a previous ED product on your own. The clinician should provide individualized instructions for any transition.
| Detail | Record |
|---|---|
| One active does not mean no interactions | Nitrates/nitrites, riociguat and other medications require assessment even after previous ED treatment. |
Availability and the actual prescription
The public access statement is Public product listing; individual eligibility and current prescription require confirmation. Service eligibility, a selectable plan and clinical suitability are different decisions. An online format may still require examination, testing or referral when the history calls for it. If a product is documented only in safety information, confirm whether the clinician can currently offer it before planning around that option or its historical price.
Refills, changes and cancellation
Before the consultation ends, ask how the response will be reviewed and who receives questions between orders. For this preparation, ask “Is the chew addressing a swallowing preference or a problem with my previous treatment?” Clarify what symptoms require prompt care and how an ordinary treatment adjustment reaches the pharmacy. The account team also needs to confirm any refill change. Neither a medical message nor a subscription setting alone proves the whole plan has been updated.
| Detail | Record |
|---|---|
| Next charge | The next order date is the charge/processing date; a first refill can be scheduled early. |
| Cancellation notice | At least 48 hours before the next order, according to support guidance. |
| Already processing | Ending a subscription does not cancel an order already processing or shipped. |
| Refund boundary | No refund guaranteed after pharmacy processing. |
| Policy sources | Hims Support: canceling a subscription · Hims Support: refund policy · Hims Support: when billing occurs |
Compare named products
The alternatives below can help articulate a preference or concern, but they are not a self-prescribing menu. Compare the exact ingredients, form and routine you would want to discuss. If several goals are bundled together, ask how each will be assessed. A different brand may offer a similar ingredient while a different product from the same brand may require an entirely new clinical explanation.
Questions to keep with the offer
This is a preparation aid based on records for Hims Sildenafil Chews, not a clinical assessment or a private patient portal. No consultation, prescribing decision or outcome was observed for the review, and there is no medical-review sign-off. Use the sources to ask clearer questions, while leaving the diagnosis, suitability and directions to the professionals responsible for your care.
| Detail | Record |
|---|---|
| Ask about this formula | Is the chew addressing a swallowing preference or a problem with my previous treatment? |
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Source documents
Provider documents establish what is advertised. Clinical and regulatory documents have different roles and do not independently verify the provider’s actual care.
- Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices · Checked 2026-10-07
- Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing · Checked 2026-10-07
- Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing · Checked 2026-10-07
- Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals · Checked 2026-10-07
- Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation · Checked 2026-10-07
- MedlinePlus: SildenafilDrug information; standard sildenafil products · Checked 2026-10-07
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications · Checked 2026-10-07
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination · Checked 2026-10-07
- MedlinePlus: TadalafilDrug information; standard tadalafil products · Checked 2026-10-07